Blog
Türkiye’s M&A landscape: What’s on the horizon for 2025?
In 2025, we expect that M&A will remain a key strategic tool for companies to drive growth. In this article, we will exp...
Blog
In 2025, we expect that M&A will remain a key strategic tool for companies to drive growth. In this article, we will exp...
Podcast
Rahel Avigdor, Managing Director of Consumer ABS at KBRA, joins host Patrick Dolan to discuss trends in auto loan securi...
Publication
Biotechnology companies are primarily built around platform technologies and focused on asset specific value creation.
Blog
In 2025, we expect that M&A will remain a key strategic tool for companies to drive growth. In this article, we will exp...
Podcast
Rahel Avigdor, Managing Director of Consumer ABS at KBRA, joins host Patrick Dolan to discuss trends in auto loan securi...
© Norton Rose Fulbright US LLP 2025